NCT01914939: A trial that was reported late by Massachusetts General Hospital
This trial has reported, although it was 1108 days late in doing so.
Full data
Full entry on ClinicalTrials.gov | NCT01914939 |
---|---|
Title | A Randomized, Controlled Trial of Intranasal Oxytocin as an Adjunct to Behavioral Therapy for Autism Spectrum Disorder |
Results Status | Reported (late) |
ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
Start date | April 30, 2014 |
Completion date | Nov. 30, 2017 |
Required reporting date | Nov. 30, 2018, midnight |
Actual reporting date | Dec. 12, 2021 |
Date last checked at ClinicalTrials.gov | Feb. 9, 2024 |
Days late | 1108 |